Findings from Southern Medical University Broaden Understanding of Selective Phosphodiesterase-4 Inhibitors (Roflumilast Ameliorates Cognitive Impairment In App/ps1 Mice Via Camp/creb/bdnf Signaling and Anti-neuroinflammatory Effects)

Source :: Obesity, Fitness & Wellness Week. May 4, 2019, 1287
Publication Year :: 2019
Abstract: 2019 MAY 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Drugs and Therapies - Selective Phosphodiesterase-4 Inhibitors have [...]

Subjects :: Dosage and administration
Research
Roflumilast -- Dosage and administration
Cognitive disorders -- Research
Brain-derived neurotrophic factor -- Research
Phosphodiesterases -- Research
Obesity
Adenosine monophosphate
Nausea
Cyclic adenosine monophosphate
Physical fitness
Editors

Tools